The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Irbesartan HCT Zentiva

Zentiva k.s.EU/1/06/377/1-5,11-16

Main Information

Trade NameIrbesartan HCT Zentiva
Active SubstancesHydrochlorothiazide
Dosage FormTablet
Licence HolderZentiva k.s.
Licence NumberEU/1/06/377/1-5,11-16

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics
C09DA04 irbesartan and diuretics


License statusAuthorised
Licence Issued19/01/2007
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back